Logo image of ARBK

ARGO BLOCKCHAIN PLC (ARBK) Stock Fundamental Analysis

NASDAQ:ARBK - Nasdaq - US0401261047 - ADR - Currency: USD

0.459  -0.03 (-5.94%)

After market: 0.4699 +0.01 (+2.37%)

Fundamental Rating

2

ARBK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. Both the profitability and financial health of ARBK have multiple concerns. While showing a medium growth rate, ARBK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ARBK has reported negative net income.
ARBK had a positive operating cash flow in the past year.
In multiple years ARBK reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARBK reported negative operating cash flow in multiple years.
ARBK Yearly Net Income VS EBIT VS OCF VS FCFARBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M -200M

1.2 Ratios

ARBK has a worse Return On Assets (-173.82%) than 95.29% of its industry peers.
Industry RankSector Rank
ROA -173.82%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARBK Yearly ROA, ROE, ROICARBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

With a Gross Margin value of 11.36%, ARBK is not doing good in the industry: 88.04% of the companies in the same industry are doing better.
ARBK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ARBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.4%
GM growth 5YN/A
ARBK Yearly Profit, Operating, Gross MarginsARBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -200 -400

1

2. Health

2.1 Basic Checks

ARBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ARBK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ARBK Yearly Shares OutstandingARBK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 10M 20M 30M 40M
ARBK Yearly Total Debt VS Total AssetsARBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

ARBK has an Altman-Z score of -9.14. This is a bad value and indicates that ARBK is not financially healthy and even has some risk of bankruptcy.
ARBK has a worse Altman-Z score (-9.14) than 88.77% of its industry peers.
ARBK has a debt to FCF ratio of 5.56. This is a neutral value as ARBK would need 5.56 years to pay back of all of its debts.
ARBK has a Debt to FCF ratio (5.56) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.56
Altman-Z -9.14
ROIC/WACCN/A
WACC19.93%
ARBK Yearly LT Debt VS Equity VS FCFARBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.52 indicates that ARBK may have some problems paying its short term obligations.
ARBK has a worse Current ratio (0.52) than 92.39% of its industry peers.
A Quick Ratio of 0.52 indicates that ARBK may have some problems paying its short term obligations.
ARBK has a worse Quick ratio (0.52) than 92.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
ARBK Yearly Current Assets VS Current LiabilitesARBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.04% over the past year.
ARBK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.19%.
Measured over the past years, ARBK shows a very strong growth in Revenue. The Revenue has been growing by 131.25% on average per year.
EPS 1Y (TTM)81.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.12%
Revenue 1Y (TTM)15.19%
Revenue growth 3Y28.27%
Revenue growth 5Y131.25%
Sales Q2Q%-28.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, ARBK will show a very strong growth in Revenue. The Revenue will grow by 47.84% on average per year.
EPS Next Y97%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.51%
Revenue Next 2Y59.65%
Revenue Next 3Y47.84%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ARBK Yearly Revenue VS EstimatesARBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ARBK Yearly EPS VS EstimatesARBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

ARBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARBK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARBK Price Earnings VS Forward Price EarningsARBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

99.28% of the companies in the same industry are more expensive than ARBK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.07
EV/EBITDA N/A
ARBK Per share dataARBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ARBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARGO BLOCKCHAIN PLC

NASDAQ:ARBK (2/21/2025, 8:01:35 PM)

After market: 0.4699 +0.01 (+2.37%)

0.459

-0.03 (-5.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2024-08-28/bmo
Earnings (Next)04-23 2025-04-23/amc
Inst Owners8.14%
Inst Owner Change-32.33%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap29.21M
Analysts40
Price Target1.22 (165.8%)
Short Float %3.59%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)51.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.05%
EPS NY rev (3m)-9.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF 4.07
P/OCF 4.36
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.91
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.11
FCFY24.55%
OCF(TTM)0.11
OCFY22.91%
SpS1.1
BVpS-0.31
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -173.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.36%
FCFM 10.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.4%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.56
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -9.14
F-ScoreN/A
WACC19.93%
ROIC/WACCN/A
Cap/Depr(3y)492.04%
Cap/Depr(5y)436.52%
Cap/Sales(3y)119.98%
Cap/Sales(5y)108.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.12%
EPS Next Y97%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.19%
Revenue growth 3Y28.27%
Revenue growth 5Y131.25%
Sales Q2Q%-28.36%
Revenue Next Year-7.51%
Revenue Next 2Y59.65%
Revenue Next 3Y47.84%
Revenue Next 5YN/A
EBIT growth 1Y67.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.37%
FCF growth 3Y57.17%
FCF growth 5YN/A
OCF growth 1Y104.31%
OCF growth 3Y8.67%
OCF growth 5YN/A